3
Total investments
1
Early stage
0
Mid stage
2
Late stage
5y
Years active
Portfolio
3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Oct 2023
At i5growth, we back bold founders, scalable technology, and transformative business models.
We partner with high-potential startups, combining strategic backing with hands-on support. Our focus is on building value-driven, globally competitive companies with lasting impact. i5growth operates long-term with a founder-first approach.
Investor & Advisory Board
2022
Explore the platform for protein and drug discovery.
Innophore is a cutting-edge drug and enzyme discovery platform that uses an artificial intelligence guided point-cloud technology to identify and optimize protein candidates for various use cases. We have leading global customers in the biotech and pharmaceutical industry, including Henkel, Continental, Merck and leading companies in the field of flavours and fragrances.
Our AI-driven platform, fueled by massive computing power, not only analyzes a protein’s 3D structure, but includes extended surface properties (HALOS) and volumetric cavities (catalophores), to predict its characteristics and reactivity. This puts our customers at the forefront of tackling problems in drug discovery/repurposing and opens new ways in the sustainable production of high-value compounds.
Accelerate your R&D pipeline.
Over the course of 20 years, protein structure database entries have grown from 13,587 to nearly a billion. This includes a recently published breakthrough database from DeepMind and the ESM Metagenomic Atlas. It is easy to get lost in the vast amount of bioinformatics information available to us today.
To identify new drug candidates or enzymes based on this vast amount of data, we need to change the way we search and go beyond traditional algorithms and data types. By integrating our patented CatalophoreTM technology with a state-of-the-art conventional bioinformatics approach, as well as artificial intelligence, we are able to mine structural and sequence databases using three-dimensional (3D) search templates called “catalophores” (i.e., carrier of the catalytic function) defined by point clouds of physicochemical features.
The Inventors of Catalophores.
Our CatalophoreTM platform improves your wet-lab performance by minimizing the volume of in-vitro screening experiments. Our in-silico approach significantly decreases time to market and increases the probability of your success.
Investor & Board Advisor
2021
planqcs quantum computers store information in individual atoms – natures best qubits. Quantum information is processed by arranging these qubits in highly scalable arrays and manipulating them with precisely controlled laser pulses. planqc’s unique combination of quantum technologies is the fastest way to scale to thousands of qubits, a prerequisite for industry-relevant quantum advantage.
planqcs founding team combines decades of international research on neutral-atom quantum technologies. Our quantum computers are built on the precision of the world’s best atomic clocks, the world’s best quantum gas microscopes, and high-speed Rydberg gates.
planqc is the first startup to emerge from the Munich Quantum Valley, which with its vast network of research institutes and industrial partners fosters a unique quantum ecosystem for startups.
Experience · 11 entries
All (11)
Investments (3)
Founder (2)
Board (1)
2025
Co-Founder & CEO
2025
Nejo is a job search engine that looks way beyond job titles. You can search three ways: chat with AI, upload your resume, or use a standard search bar. We crawl the web in real-time to find job postings and surface matches based on your actual skills and career goals. Our mission? Make the job market transparent and accessible for everyone. We help people find jobs and career paths they might otherwise have never discovered.
2023
Board Member
Oct 2023
At i5growth, we back bold founders, scalable technology, and transformative business models.
We partner with high-potential startups, combining strategic backing with hands-on support. Our focus is on building value-driven, globally competitive companies with lasting impact. i5growth operates long-term with a founder-first approach.
2022
Investor & Advisory Board
2022
Explore the platform for protein and drug discovery.
Innophore is a cutting-edge drug and enzyme discovery platform that uses an artificial intelligence guided point-cloud technology to identify and optimize protein candidates for various use cases. We have leading global customers in the biotech and pharmaceutical industry, including Henkel, Continental, Merck and leading companies in the field of flavours and fragrances.
Our AI-driven platform, fueled by massive computing power, not only analyzes a protein’s 3D structure, but includes extended surface properties (HALOS) and volumetric cavities (catalophores), to predict its characteristics and reactivity. This puts our customers at the forefront of tackling problems in drug discovery/repurposing and opens new ways in the sustainable production of high-value compounds.
Accelerate your R&D pipeline.
Over the course of 20 years, protein structure database entries have grown from 13,587 to nearly a billion. This includes a recently published breakthrough database from DeepMind and the ESM Metagenomic Atlas. It is easy to get lost in the vast amount of bioinformatics information available to us today.
To identify new drug candidates or enzymes based on this vast amount of data, we need to change the way we search and go beyond traditional algorithms and data types. By integrating our patented CatalophoreTM technology with a state-of-the-art conventional bioinformatics approach, as well as artificial intelligence, we are able to mine structural and sequence databases using three-dimensional (3D) search templates called “catalophores” (i.e., carrier of the catalytic function) defined by point clouds of physicochemical features.
The Inventors of Catalophores.
Our CatalophoreTM platform improves your wet-lab performance by minimizing the volume of in-vitro screening experiments. Our in-silico approach significantly decreases time to market and increases the probability of your success.
2021
Advisory Board & Strategic Partnerships
2021
Auphonic develops intelligent audio algorithms using a combination of AI and signal processing to provide an automated audio post-production web service — an audio autopilot for podcasts, broadcasts, radio, interviews, audiobooks, lecture recordings, and more. Users just upload their recorded audio, and Auphonic will do the rest: neither complicated parameter settings nor audio expert knowledge are necessary.
Hundreds of thousands of users rely on our services and algorithms, which adapt to new data daily. We are happy to continue being the to-go tool for post-production for any level of user expertise and give our fans what they want: perfectly edited audio within seconds.
Investor & Board Advisor
2021
planqcs quantum computers store information in individual atoms – natures best qubits. Quantum information is processed by arranging these qubits in highly scalable arrays and manipulating them with precisely controlled laser pulses. planqc’s unique combination of quantum technologies is the fastest way to scale to thousands of qubits, a prerequisite for industry-relevant quantum advantage.
planqcs founding team combines decades of international research on neutral-atom quantum technologies. Our quantum computers are built on the precision of the world’s best atomic clocks, the world’s best quantum gas microscopes, and high-speed Rydberg gates.
planqc is the first startup to emerge from the Munich Quantum Valley, which with its vast network of research institutes and industrial partners fosters a unique quantum ecosystem for startups.
Show all 11 entries ↓
Investment activity
2021–2023 · 3 investments
Recent (last 2 years)Earlier
